Bromocriptine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01200 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | congenital disorder of glycosylation with defective fucosylation | KG + DL |
| 2 | polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis | KG + DL |
| 3 | retinal dystrophy with or without extraocular anomalies | KG + DL |
| 4 | atypical glycine encephalopathy | KG + DL |
| 5 | myopia 26, X-linked, female-limited | KG + DL |
| 6 | hydranencephaly (disease) | KG + DL |
| 7 | myopia X-linked | KG + DL |
| 8 | Charcot-Marie-Tooth disease, demyelinating, type 1G | KG + DL |
| 9 | schizophrenia | KG + DL |
| 10 | syndromic myopia | KG + DL |
| 11 | ACTH-producing pituitary gland neoplasm | KG + DL |
| 12 | functioning pituitary gland neoplasm | KG + DL |
| 13 | pituitary gland basophilic carcinoma | KG + DL |
| 14 | ACTH-producing pituitary gland carcinoma | KG + DL |
| 15 | faciodigitogenital syndrome | KG + DL |
| 16 | vaginal neoplasm | KG + DL |
| 17 | benign neoplasm of pituitary gland | KG + DL |
| 18 | sella turcica neoplasm | KG + DL |
| 19 | benign female reproductive system neoplasm | KG + DL |
| 20 | attention deficit-hyperactivity disorder | KG + DL |
| 21 | endometrioid stromal and related neoplasms | KG + DL |
| 22 | posterior pituitary gland neoplasm | KG + DL |
| 23 | cerebral palsy, spastic quadriplegic | KG + DL |
| 24 | multiple fibroadenoma of the breast | KG + DL |
| 25 | trichotillomania | KG + DL |
| 26 | PLA2G6-associated neurodegeneration | KG + DL |
| 27 | endometrioid stromal and related neoplasms of the cervix | KG + DL |
| 28 | pituitary cancer | KG + DL |
| 29 | renal-hepatic-pancreatic dysplasia | KG + DL |
| 30 | pituitary adenocarcinoma (disease) | KG + DL |
| 31 | Joubert syndrome with renal defect | KG + DL |
| 32 | transaldolase deficiency | KG + DL |
| 33 | febrile infection-related epilepsy syndrome | KG + DL |
| 34 | Lennox-Gastaut syndrome | KG + DL |
| 35 | polycystic kidney disease 3 with or without polycystic liver disease | KG + DL |
| 36 | perioral myoclonia with absences | KG + DL |
| 37 | thoracic malformation | KG + DL |
| 38 | fructose-1,6-bisphosphatase deficiency | KG + DL |
| 39 | Rasmussen subacute encephalitis | KG + DL |
| 40 | karyomegalic interstitial nephritis | KG + DL |
| 41 | adult familial nephronophthisis-spastic quadriparesia syndrome | KG + DL |
| 42 | photosensitive occipital lobe epilepsy | KG + DL |
| 43 | atypical childhood epilepsy with centrotemporal spikes | KG + DL |
| 44 | cryptogenic late-onset epileptic spasms | KG + DL |
| 45 | familial congenital mirror movements | KG + DL |
| 46 | X-linked intellectual disability-ataxia-apraxia syndrome | KG + DL |
| 47 | Lewy body dementia | KG + DL |
| 48 | X-linked intellectual disability-cerebellar hypoplasia syndrome | KG + DL |
| 49 | CDKL5 disorder | KG + DL |
| 50 | lissencephaly type 1 due to doublecortin gene mutation | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.